KNUSTSpace >
Kumasi Center for Collaborative Research (KCCR) >
Publications >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/7112
|
Title: | Malaria intervention policies and pharmaceutical nanotechnology as a potential tool for malaria management |
Authors: | Kuntworbe, Noble Martini, Nataly Shaw, John Al-Kassas, Raida |
Keywords: | malaria pharmaceutical nanotechnology malaria prevention malaria diagnosis malaria treatment antimalarial drug resistance |
Issue Date: | 2012 |
Publisher: | Drug Development Research |
Citation: | Drug Development Research 73 : 167–184 (2012) |
Abstract: | In order to better understand the persistence of malaria, it is timely to reflect on the various
approaches toward its eradication and to consider what is being done well and to identify what needs to
be improved. This review explores currently available tools and policies designed to eradicate malaria and
the potential difficulties associated with each. We have also considered pharmaceutical nanotechnology
as a possible tool in the fight against malaria. Each policy, ranging from the adaption of combination drug
therapy to the deployment of insecticide-treated nets was considered to be laudable. The implementation
and coverage of policies, however, exposed many gaps with persistence of the disease. Some of the
challenges identified include misdiagnosis, production and distribution of fake and substandard antimalarial
drugs, misapplication of insecticides, poor infrastructure, lack of sociopolitical will, and conflicts
leading to displacement of people. Failure of malaria eradication has been attributed to the development
of multiple drug resistance and the side effects associated with the use of conventional antimalarial
chemotherapy. The review identified nanotechnology as a formulation strategy that has the potential to
improve the safety and efficacy of drug therapy and help the cause of malaria eradication. In conclusion,
this review is expected to provide a better understanding of the policies on malaria eradication and
challenges associated with each of them. It also suggests that nanotechnology has the potential to reduce
side effects of antimalarial drugs and improve their efficacy and should be given serious attention. Drug
Dev Res 73 : 167–184, 2012. © 2012 Wiley Periodicals, Inc. |
Description: | Article published in Drug Development Research 73 : 167–184 (2012) |
URI: | http://hdl.handle.net/123456789/7112 |
Appears in Collections: | Publications
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|